A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis
Latest Information Update: 08 Apr 2022
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Incyte Corporation
Most Recent Events
- 04 Apr 2022 Results published in the American Journal of Clinical Dermatology
- 12 Feb 2020 Status changed from active, no longer recruiting to completed.
- 18 Dec 2019 Status changed from recruiting to active, no longer recruiting.